Coralie Poncet

Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program

Fátima Cardoso, John M.S. Bartlett, Leen Slaets et al. · Annals of Oncology · 2017 · 381 citations · Full text

Eortc 10085/Tbcrc/big/nabcg, Breast Oncology, Medicine +7

70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age

Martine Piccart, Laura van ‘t Veer, Coralie Poncet et al. · The Lancet Oncology · 2021 · 336 citations · Full text

Breast Oncology, Early Breast Cancer, Medicine +11

Radiotherapy or Surgery of the Axilla After a Positive Sentinel Node in Breast Cancer: 10-Year Results of the Randomized Controlled EORTC 10981-22023 AMAROS Trial

Sanne A. L. Bartels, Mila Donker, Coralie Poncet et al. · Journal of Clinical Oncology · 2022 · 322 citations · Full text

Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti–Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer

Marion van Mackelenbergh, Sibylle Loibl, Michael Untch et al. · Journal of Clinical Oncology · 2023 · 90 citations

MINDACT: Long-term results of the large prospective trial testing the 70-gene signature MammaPrint as guidance for adjuvant chemotherapy in breast cancer patients.

Fátima Cardoso, Laura van ‘t Veer, Coralie Poncet et al. · Journal of Clinical Oncology · 2020 · 63 citations

Breast Oncology, Cancer Management, Adjuvant Chemotherapy +19